H-SLLMWITQCFLPVF-OH

Ref. 3D-PP48621

Información del producto

• Nombre: H-SLLMWITQCFLPVF-OH

Descripción

Peptide H-SLLMWITQCFLPVF-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SLLMWITQCFLPVF-OH include the following: Efficient cross-priming of tumor antigen-specific T cells by dendritic cells sensitized with diverse anti-MICA opsonized tumor cells V Groh, YQ Li, D Cioca, NN Hunder - Proceedings of the , 2005 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.0501953102 Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma T Nicholaou, LM Ebert , ID Davis , GA McArthur - Clinical Cancer , 2009 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/15/6/2166/74537 Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1 NN Hunder, H Wallen, J Cao - England Journal of , 2008 - Mass Medical Sochttps://www.nejm.org/doi/full/10.1056/NEJMoa0800251 Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer K Odunsi , F Qian, J Matsuzaki - Proceedings of the , 2007 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.0703342104 Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation K Birkholz, M Schwenkert, C Kellner - Blood, The Journal , 2010 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/116/13/2277/27558 Cell-sized lipid vesicles as artificial antigen-presenting cells for antigen-specific T cell activation JY Chen , S Agrawal , HP Yi, D Vallejo - Advanced , 2023 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/adhm.202203163 The Role of Proteases in Processing of Tumour Associated Antigen (NY-ES0-1) J Alhoderi , FA Matough , A Rahimli - Journal of Pure & Applied , 2018 - sebhau.edu.lyhttps://sebhau.edu.ly/journal/jopas/article/view/172 NY-ESO-1 Protein Formulated in ISCOMATRIX Adjuvant Is a Potent Anticancer Vaccine Inducing Both Humoral and CD8+ T-Cell-Mediated Immunity and Protection against NY E Maraskovsky, S Sjölander, DP Drane - Clinical cancer , 2004 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/10/8/2879/185185 The bright side of chemistry: Exploring synthetic peptide-based anticancer vaccines A D'Aniello, A Del Bene, S Mottola - Journal of Peptide , 2024 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/psc.3596

• Marca: Biosynth